Cargando…
Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis
Objectives: To analyze the differences in cost-effectiveness between primary ureteroscopy and ureteric stenting in patients with ureteric calculi in the emergency setting. Patients and Methods: Patients requiring emergency intervention for a ureteric calculus at a tertiary centre were analysed betwe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697827/ https://www.ncbi.nlm.nih.gov/pubmed/36579512 http://dx.doi.org/10.3390/jpm12111773 |
_version_ | 1784838664923119616 |
---|---|
author | Sehgal, Radha Abu-Ghanem, Yasmin Fontaine, Christina Forster, Luke Goyal, Anuj Allen, Darrell Kucheria, Rajesh Singh, Paras Ellis, Gidon Ajayi, Leye |
author_facet | Sehgal, Radha Abu-Ghanem, Yasmin Fontaine, Christina Forster, Luke Goyal, Anuj Allen, Darrell Kucheria, Rajesh Singh, Paras Ellis, Gidon Ajayi, Leye |
author_sort | Sehgal, Radha |
collection | PubMed |
description | Objectives: To analyze the differences in cost-effectiveness between primary ureteroscopy and ureteric stenting in patients with ureteric calculi in the emergency setting. Patients and Methods: Patients requiring emergency intervention for a ureteric calculus at a tertiary centre were analysed between January and December 2019. The total secondary care cost included the cost of the procedure, inpatient hospital bed days, emergency department (A&E) reattendances, ancillary procedures and any secondary definitive procedure. Results: A total of 244 patients were included. Patients underwent ureteric stenting (62.3%) or primary treatment (37.7%), including primary ureteroscopy (URS) (34%) and shock wave lithotripsy (SWL) (3.6%). The total secondary care cost was more significant in the ureteric stenting group (GBP 4485.42 vs. GBP 3536.83; p = 0.65), though not statistically significant. While mean procedural costs for primary treatment were significantly higher (GBP 2605.27 vs. GBP 1729.00; p < 0.001), costs in addition to the procedure itself were significantly lower (GBP 931.57 vs. GBP 2742.35; p < 0.001) for primary treatment compared to ureteric stenting. Those undergoing ureteric stenting had a significantly higher A&E reattendance rate compared with primary treatment (25.7% vs. 10.9%, p = 0.02) and a significantly greater cost per patient related to revisits to A&E (GBP 61.05 vs. GBP 20.87; p < 0.001). Conclusion: Primary definitive treatment for patients with acute ureteric colic, although associated with higher procedural costs than ureteric stenting, infers a significant reduction in additional expenses, notably related to fewer A&E attendances. This is particularly relevant in the COVID-19 era, where it is crucial to avoid unnecessary attendances to A&E and reduce the backlog of delayed definitive procedures. Primary treatment should be considered concordance with clinical judgement and factors such as patient preference, equipment availability and operator experience. |
format | Online Article Text |
id | pubmed-9697827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96978272022-11-26 Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis Sehgal, Radha Abu-Ghanem, Yasmin Fontaine, Christina Forster, Luke Goyal, Anuj Allen, Darrell Kucheria, Rajesh Singh, Paras Ellis, Gidon Ajayi, Leye J Pers Med Article Objectives: To analyze the differences in cost-effectiveness between primary ureteroscopy and ureteric stenting in patients with ureteric calculi in the emergency setting. Patients and Methods: Patients requiring emergency intervention for a ureteric calculus at a tertiary centre were analysed between January and December 2019. The total secondary care cost included the cost of the procedure, inpatient hospital bed days, emergency department (A&E) reattendances, ancillary procedures and any secondary definitive procedure. Results: A total of 244 patients were included. Patients underwent ureteric stenting (62.3%) or primary treatment (37.7%), including primary ureteroscopy (URS) (34%) and shock wave lithotripsy (SWL) (3.6%). The total secondary care cost was more significant in the ureteric stenting group (GBP 4485.42 vs. GBP 3536.83; p = 0.65), though not statistically significant. While mean procedural costs for primary treatment were significantly higher (GBP 2605.27 vs. GBP 1729.00; p < 0.001), costs in addition to the procedure itself were significantly lower (GBP 931.57 vs. GBP 2742.35; p < 0.001) for primary treatment compared to ureteric stenting. Those undergoing ureteric stenting had a significantly higher A&E reattendance rate compared with primary treatment (25.7% vs. 10.9%, p = 0.02) and a significantly greater cost per patient related to revisits to A&E (GBP 61.05 vs. GBP 20.87; p < 0.001). Conclusion: Primary definitive treatment for patients with acute ureteric colic, although associated with higher procedural costs than ureteric stenting, infers a significant reduction in additional expenses, notably related to fewer A&E attendances. This is particularly relevant in the COVID-19 era, where it is crucial to avoid unnecessary attendances to A&E and reduce the backlog of delayed definitive procedures. Primary treatment should be considered concordance with clinical judgement and factors such as patient preference, equipment availability and operator experience. MDPI 2022-10-27 /pmc/articles/PMC9697827/ /pubmed/36579512 http://dx.doi.org/10.3390/jpm12111773 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sehgal, Radha Abu-Ghanem, Yasmin Fontaine, Christina Forster, Luke Goyal, Anuj Allen, Darrell Kucheria, Rajesh Singh, Paras Ellis, Gidon Ajayi, Leye Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title | Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title_full | Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title_fullStr | Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title_full_unstemmed | Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title_short | Primary Definitive Treatment versus Ureteric Stenting in the Management of Acute Ureteric Colic: A Cost-Effectiveness Analysis |
title_sort | primary definitive treatment versus ureteric stenting in the management of acute ureteric colic: a cost-effectiveness analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697827/ https://www.ncbi.nlm.nih.gov/pubmed/36579512 http://dx.doi.org/10.3390/jpm12111773 |
work_keys_str_mv | AT sehgalradha primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT abughanemyasmin primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT fontainechristina primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT forsterluke primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT goyalanuj primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT allendarrell primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT kucheriarajesh primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT singhparas primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT ellisgidon primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis AT ajayileye primarydefinitivetreatmentversusuretericstentinginthemanagementofacuteuretericcolicacosteffectivenessanalysis |